LSA
ELV icon

L & S Advisors’s Elevance Health ELV Stock Holding History

L & S Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,470
Closed -$5.78M – 290
2021
Q4 		$5.78M Buy
+12,470
New +$5.25M 0.62% 49
2020
Q3 		– Sell
-4,312
Closed -$1.13M – 318
2020
Q2 		$1.13M Buy
+4,312
New +$1.15M 0.17% 154
2019
Q3 		– Sell
-5,600
Closed -$1.58M – 321
2019
Q2 		$1.58M Buy
5,600
+1,731
+45% +$473K 0.21% 120
2019
Q1 		$1.11M Sell
3,869
-981
-20% -$284K 0.15% 156
2018
Q4 		$1.27M Buy
+4,850
New +$1.33M 0.24% 84

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

L & S Advisors's ELV Position: Q1 2022 in Review

L & S Advisors sold out of Elevance Health (ELV) in Q1 2022, closing a stake of 12,470 shares — an estimated $5.78M sold.

L & S Advisors first reported a position in ELV in Q4 2018 and held it in 5 quarters. The position peaked at $5.78M in Q4 2021. 1,418 funds tracked by Wall St. Rank hold ELV as of Q1 2022.

  • L & S Advisors reported no remaining Elevance Health position as of Q1 2022 after selling out during the quarter.
  • L & S Advisors sold 12,470 Elevance Health shares in Q1 2022, an estimated $5.78M.
  • L & S Advisors first reported a position in Elevance Health in Q4 2018 and held it in 5 quarters.
  • L & S Advisors's Elevance Health position peaked at $5.78M in Q4 2021.
  • 1,418 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.

Based on L & S Advisors's 13F filing for Q1 2022, filed 11 May 2022.